Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-23-002021

Options or other derivatives

  • CEO and Director acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Meckler Jeffrey A CEO and Director 2023-01-18 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/ownership.xml…